Benzinga's Top #PreMarket Losers

By: via Benzinga
Seres Therapeutics Inc (NASDAQ: MCRB) shares declined 14.40 percent to $44.00 in pre-market trading after jumping 185.56 percent on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.